• Pulse Biosciences COO Liane Rae Teplitsky bought 2,070 common shares in open-market transactions.
• Purchases were priced at USD 48.24 to USD 48.35 per share.
• Her direct holding rose to 2,070 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulse Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-029233), on August 28, 2026, and is solely responsible for the information contained therein.